Unresolved
We still don’t know whether anyone at this organisation has actually used this technology — zero lived-experience observations exist.
Not yet answered
What are we missing?
HealthAratus Intelligence
Baxter
Baxter Intelligence
What the accumulated evidence, deployment record and lived experience actually show.
Intelligence lenses
Four ways of interrogating the same reality. Each changes the question, not the subject.
Do published findings about Baxter match what happens in practice?
Public evidence
Baxter hires CFO from Smith Nephew
MedTech Dive
Public evidence
Ambient Clinical Analytics Raises $5M, Appoints Brian Tufts as CEO
HIT Consultant
What we know · what we don’t
Everything here is open to being corrected by someone who has seen it first-hand.
What we still don’t know
Nobody has answered these yet. Your experience can help us understand what is happening.
Matters of record
Settled elsewhere. Context for reading the above, not something practice can confirm.
- 2 public external signal(s) across 2 source(s).Recorded by HealthAratus
Tool intelligence
What HealthAratus understands
HealthAratus currently understands Baxter through regulatory records, deployment evidence and external market activity.
- Category
- imaging_diagnostics
What HealthAratus is still learning
HealthAratus is beginning to understand Baxter. As evidence and experience accumulate, what remains unclear will be stated here.
Evidence & claims
What this is built on
The material the questions above were built from, with its attribution.
Baxter provides automated peritoneal dialysis systems and the Sharesource remote patient management platform. These tools allow healthcare providers to monitor and adjust patient therapy settings from a distance.
Stated capabilities
The vendor’s own claims. Testable where practice can actually test them.
Stated capability
Clinicians can remotely monitor patient dialysis treatment data using the Sharesource platform.
According to Baxter
Does this change your workflow?
Independent and public evidence
Found in public sources. Not a clinician’s experience, and never presented as one.
Reported deployment
Baxter hires CFO from Smith Nephew
According to MedTech Dive
How widely is this actually used?
Recent change
Ambient Clinical Analytics Raises $5M, Appoints Brian Tufts as CEO
According to HIT Consultant
Have you noticed this shift?
Company participation
Not yet verified
A record of the reality forming around this technology already exists. No representative of the company has verified participation yet.
Claim your company profileReference
The stable facts, for interpreting everything above.
Overview
What it does
• Baxter offers comprehensive renal care solutions, including peritoneal dialysis (PD) systems, home hemodialysis equipment, and connected health platforms. Their automated PD systems, such as Homechoice Claria and Amia, integrate with the Sharesource remote patient management platform, enabling healthcare providers…
Vendor & external product information, not independently verified by HealthAratus
Where it's used
Deployed in home settings, US, Canada, Europe, Asia, Latin America
Key strength
Regulatory: FDA clearance for Homechoice Claria and Amia APD systems, CE mark for Homechoice Claria APD system
Key capabilities
Automated peritoneal dialysis systems with integrated remote monitoring, User-friendly interfaces featuring voice guidance and touchscreen controls, Compact and portable design for therapy continuity during travel
Clinical use cases
Remote monitoring of home peritoneal dialysis treatments, Personalized therapy adjustments based on real-time data, Enhancing patient adherence to dialysis regimens
Who uses it
Patients undergoing peritoneal dialysis, Healthcare providers managing home dialysis therapies, Renal care specialists seeking integrated patient management solutions
How the reality here has changed
Not enough recorded activity across time yet to describe how the reality here has moved. As accounts of Baxter accumulate, this becomes a record of how the reality moved rather than a snapshot of one moment.
Across the category
Baxter against the rest of Imaging & Diagnostics
Category intelligence reads this as Established. A sample of peers, not a census of the category.
Where Baxter may differ
Differences in what we have recorded. Never a ranking, never a quality judgement.
No first-hand account has been recorded for Baxter or for any peer we sampled in this category.
A gap across the whole category, not a fact about this technology.
Two readings that disagree
- Category intelligence reads clinical reality here as "Expanding", yet no first-hand account appears in the systems we sampled. Both readings are shown rather than reconciled.
Used another system in Imaging & Diagnostics? How does your experience compare?
A comparison across two systems tests the category, not just one product.
Connected intelligence
Category intelligence